Colgate-Palmolive (NYSE:CL) Shares Sold by BBR Partners LLC

BBR Partners LLC decreased its position in shares of Colgate-Palmolive (NYSE:CL) by 2.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,950 shares of the company’s stock after selling 131 shares during the period. BBR Partners LLC’s holdings in Colgate-Palmolive were worth $618,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the company. B. Riley Wealth Advisors Inc. boosted its stake in Colgate-Palmolive by 0.8% during the first quarter. B. Riley Wealth Advisors Inc. now owns 16,639 shares of the company’s stock valued at $1,498,000 after buying an additional 138 shares in the last quarter. Hancock Whitney Corp grew its stake in shares of Colgate-Palmolive by 1.3% in the 1st quarter. Hancock Whitney Corp now owns 12,017 shares of the company’s stock worth $1,082,000 after purchasing an additional 151 shares during the last quarter. Citizens Financial Group Inc. RI grew its stake in shares of Colgate-Palmolive by 12.4% in the 1st quarter. Citizens Financial Group Inc. RI now owns 14,082 shares of the company’s stock worth $1,268,000 after purchasing an additional 1,549 shares during the last quarter. LRI Investments LLC bought a new stake in shares of Colgate-Palmolive in the 1st quarter worth approximately $264,000. Finally, Atria Investments Inc boosted its holdings in Colgate-Palmolive by 3.2% during the first quarter. Atria Investments Inc now owns 67,625 shares of the company’s stock worth $6,090,000 after buying an additional 2,115 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have issued reports on CL shares. Stifel Nicolaus cut Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price target for the company from $105.00 to $101.00 in a report on Monday, October 28th. StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday. Piper Sandler initiated coverage on Colgate-Palmolive in a research note on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 price target on the stock. UBS Group boosted their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Finally, Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a report on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $105.11.

Colgate-Palmolive Trading Up 0.2 %

Shares of NYSE CL opened at $96.75 on Thursday. The business has a 50 day simple moving average of $97.61 and a 200 day simple moving average of $98.58. Colgate-Palmolive has a 52 week low of $75.50 and a 52 week high of $109.30. The stock has a market cap of $79.05 billion, a price-to-earnings ratio of 27.72, a PEG ratio of 3.40 and a beta of 0.42. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.07%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is 57.31%.

Insider Transactions at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.37% of the stock is currently owned by company insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.